GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Short Percentage of Float

Futura Medical (LSE:FUM) Short Percentage of Float


View and export this data going back to 2003. Start your Free Trial

What is Futura Medical Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Futura Medical's Short Percentage of Float

For the Biotechnology subindustry, Futura Medical's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Futura Medical's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Futura Medical's Short Percentage of Float falls into.


Futura Medical (LSE:FUM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Short Percentage of Float
Comparable Companies
LSE:FARN LSE:SCLP LSE:AVCT LSE:POLB LSE:4BB LSE:HVO LSE:AREC LSE:TRX LSE:SAR LSE:OBD OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
FAMDF:USA GYX:Germany
Address
40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Website
https://www.futuramedical.com
Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.

Futura Medical (LSE:FUM) Headlines

No Headlines